Total Payments
$2,347
2024 Payments
$1,096
Companies
17
Transactions
88
Medicare Patients
1,010
Medicare Billing
$288,142
Payment Breakdown by Category
Food & Beverage$2,282 (97.2%)
Education$64.56 (2.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,282 | 84 | 97.2% |
| Education | $64.56 | 4 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $420.69 | 10 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $336.85 | 15 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $310.25 | 5 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $289.33 | 14 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $176.80 | 7 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $152.59 | 6 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $123.71 | 4 | $0 (2024) |
| CALLIDITAS THERAPEUTICS US INC. | $120.02 | 7 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $87.26 | 6 | $0 (2020) |
| Novo Nordisk Inc | $79.33 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,096 | 43 | Amgen Inc. ($187.06) |
| 2023 | $1,042 | 38 | Amgen Inc. ($233.63) |
| 2022 | $122.22 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($122.22) |
| 2020 | $29.79 | 2 | E.R. Squibb & Sons, L.L.C. ($29.79) |
| 2019 | $57.47 | 4 | E.R. Squibb & Sons, L.L.C. ($57.47) |
All Payment Transactions
88 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: NEPHROLOGY | ||||||
| 12/13/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $133.16 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $35.21 | General |
| 12/06/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $31.89 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.99 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $5.57 | General |
| Category: Inflammation | ||||||
| 11/09/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $34.88 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $34.76 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Diabetes | ||||||
| 09/28/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: IMMUNOLOGY | ||||||
| 09/07/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $31.55 | General |
| Category: Immunology | ||||||
| 08/30/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $30.94 | General |
| Category: Immunology | ||||||
| 08/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: DIABETES | ||||||
| 08/10/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/09/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/09/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/09/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $2.12 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/31/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/26/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Nephrology | ||||||
| 07/12/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $29.15 | General |
| Category: NEPHROLOGY | ||||||
| 07/02/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Diabetes | ||||||
| 06/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Diabetes | ||||||
| 06/19/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 702 | 1,522 | $555,336 | $209,597 |
| 2022 | 9 | 308 | 714 | $211,808 | $78,545 |
Total Patients
1,010
Total Services
2,236
Medicare Billing
$288,142
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 39 | 162 | $127,980 | $51,111 | 39.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 138 | 415 | $108,730 | $43,302 | 39.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 69 | 155 | $97,030 | $28,974 | 29.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 109 | 126 | $48,132 | $18,756 | 39.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 108 | 258 | $44,892 | $17,663 | 39.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 63 | 147 | $43,806 | $17,059 | 38.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 38 | 66 | $27,456 | $10,423 | 38.0% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 18 | 26 | $17,160 | $6,889 | 40.1% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 64 | 108 | $17,064 | $6,814 | 39.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 22 | 22 | $11,132 | $4,156 | 37.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 20 | 23 | $6,578 | $2,530 | 38.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $5,376 | $1,920 | 35.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 78 | 284 | $45,440 | $17,727 | 39.0% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 30 | 50 | $40,900 | $16,002 | 39.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 59 | 155 | $35,340 | $13,911 | 39.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 27 | 66 | $42,768 | $12,488 | 29.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 41 | 43 | $19,006 | $7,454 | 39.2% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 27 | 69 | $11,178 | $4,405 | 39.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 14 | 14 | $7,224 | $2,648 | 36.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 20 | 20 | $6,000 | $2,359 | 39.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 13 | $3,952 | $1,550 | 39.2% |
About Dr. Lauren Macaraeg, M.D
Dr. Lauren Macaraeg, M.D is a Nephrology healthcare provider based in Daly City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/07/2017. The National Provider Identifier (NPI) number assigned to this provider is 1730612532.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lauren Macaraeg, M.D has received a total of $2,347 in payments from pharmaceutical and medical device companies, with $1,096 received in 2024. These payments were reported across 88 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,282).
As a Medicare-enrolled provider, Macaraeg has provided services to 1,010 Medicare beneficiaries, totaling 2,236 services with total Medicare billing of $288,142. Data is available for 2 years (2022–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Internal Medicine
- Location Daly City, CA
- Active Since 04/07/2017
- Last Updated 06/27/2022
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1730612532
Products in Payments
- JARDIANCE (Drug) $360.96
- ACTHAR (Biological) $336.85
- Aranesp (Biological) $183.54
- JYNARQUE (Drug) $176.80
- FARXIGA (Drug) $173.84
- TAVNEOS (Drug) $155.78
- Kerendia (Drug) $152.59
- TARPEYO (Drug) $120.02
- LOKELMA (Drug) $115.49
- Fabhalta (Drug) $97.25
- ELIQUIS (Drug) $87.26
- Ozempic (Drug) $79.33
- LUPKYNIS (Drug) $52.53
- XARELTO (Drug) $36.95
- KRYSTEXXA (Biological) $31.28
- EPOGEN (Biological) $29.54
- LIVTENCITY (Drug) $27.62
- RAYALDEE (Drug) $23.76
- IBSRELA (Drug) $23.14
- Parsabiv (Drug) $20.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Daly City
Dr. Christian Cruz, Md, MD
Nephrology — Payments: $64,624
Nephrology $64,624
Dr. Robert Tseng, Md, MD
Nephrology — Payments: $18,913
Nephrology $18,913
Dr. Warren Chang, Md, MD
Nephrology — Payments: $4,734
Nephrology $4,734
Dr. Hector Santiesteban, Medical Doctor, MEDICAL DOCTOR
Nephrology — Payments: $3,483
Nephrology $3,483
Dr. Albert Kao, Md, MD
Nephrology — Payments: $2,024
Nephrology $2,024
Dr. Philip Hertz, Md, MD
Nephrology
Nephrology